Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies. [PDF]
Alves BKAMF +3 more
europepmc +1 more source
Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases. [PDF]
Ordoño-Saiz MV +10 more
europepmc +1 more source
Why should a 5q spinal muscular atrophy neonatal screening program be started? [PDF]
Becker MM +5 more
europepmc +1 more source
Reabilitação em cães com atrofia muscular induzida
Pós-graduação em Cirurgia Veterinária ...
openaire +1 more source
Tratamiento de pacientes con atrofia muscular espinal 5q: hacia un nuevo protocolo
David Gómez‐Andrés +2 more
openalex +1 more source
The effects of disease-modifying therapies in SMA-5q type 1 and the importance of early diagnosis of the disease. [PDF]
Zanoteli E.
europepmc +1 more source
Impactos da Atrofia muscular espinhal tipo I ou II na função mandibular: uma revisão de escopo
Ana Paula da Silva Vidal +4 more
openalex +2 more sources
Quality of life in patients with spinal muscular atrophy in Brazil: patient self-assessment and carer perception. [PDF]
Coelho M +3 more
europepmc +1 more source

